Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» In wake of generics deal, Teva to close New York plant
In wake of generics deal, Teva to close New York plant
In wake of generics deal, Teva to close New York plant
Submitted by
admin
on September 1, 2016 - 4:44pm
Source:
BioPharma Dive
News Tags:
generics
Teva Pharmaceutical
drug manufacturing
R&D
Allergan
Actavis
Headline:
In wake of generics deal, Teva to close New York plant
Do Not Allow Advertisers to Use My Personal information
